Iteris Pioneering Smart Mobility Embraces New Chapter with Almaviva Acquisition

Iteris, Inc., a global leader in smart mobility infrastructure management, announced today a definitive agreement to be acquired by Almaviva S.p.A., a leading Italian digital innovation group, in an all-cash transaction valued at approximately $335 million. This strategic move marks a significant milestone for Iteris, solidifying its position at the forefront of intelligent transportation solutions….

Read More

Hendy HARIANTO Receives Top Honors as No.1 Recipient of The 2024 World CIO CTO 100 Award

In a remarkable achievement highlighting his outstanding leadership in IT and business process transformation, Hendy HARIANTO has been named the No.1 recipient of The 2024 World CIO CTO 100 Award by Marlow Business School. This prestigious accolade, bestowed upon him from a pool of over 1,300 global IT leaders, recognizes his profound impact and dedication…

Read More

Black Forest Labs Secures $300M Series B to Accelerate Global Visual Intelligence Leadership

Black Forest Labs, the frontier visual intelligence company behind the FLUX model family, announced a $300 million Series B financing round led by AMP and Salesforce Ventures at a post-money valuation of $3.25 billion. This follows an earlier undisclosed Series A led by Andreessen Horowitz, with contributions from BroadLight Capital, Creandum, Earlybird VC, General Catalyst,…

Read More

IdentifAI Secures €2.2M to Combat Deepfake Threats with Advanced Detection Models

Milan-based IdentifAI, a pioneering startup focused on identifying and mitigating deepfake content through cutting-edge technology, has announced a successful seed funding round, raising €2.2 million. This significant investment will fuel the company’s mission to develop sophisticated generative models that distinguish between human-created and AI-generated content. The funding round, led by United Ventures, a venture capital…

Read More

Comun Secures $21.5M Series A Funding to Revolutionize Financial Services for Immigrants

Comun, a trailblazing neobank dedicated to serving the immigrant community in the U.S., has secured a substantial $21.5 million in its Series A funding round. The investment, spearheaded by Redpoint Ventures, includes participation from notable investors such as ANIMO Ventures, Costanoa Ventures, FJ Labs, RTP Global, and South Park Commons. This funding comes on the…

Read More

iOnctura Raises EUR 80 Million to Propel Groundbreaking Cancer Treatments

iOnctura, a pioneering biopharmaceutical company specializing in innovative cancer treatments, has secured EUR 80 million in Series B financing. This milestone funding round, led by Syncona Limited with participation from the European Innovation Council (EIC) Fund and existing investors, underscores iOnctura’s transformative strides in oncology. The investment will accelerate the development of iOnctura’s lead candidate,…

Read More

FOSSA Systems Secures €6.3 Million to Expand IoT Satellite Constellation for Global Industrial Applications

FOSSA Systems, an innovative leader in space technology based in Madrid, has successfully closed a Series A funding round, raising €6.3 million to advance its pioneering IoT satellite constellation. This funding round was co-led by Indico Capital Partners and Nabtesco Technology Ventures, with additional participation from Newmind Venture and Sabadell Venture Capital. The investment will…

Read More

Tolerance Bio, Inc. Secures $17.2 Million Seed Financing to Revolutionize Thymus-Based Therapies for Immune Disorders

In a significant development for the biopharmaceutical landscape, Tolerance Bio, Inc. has announced the successful closure of its oversubscribed $17.2 million seed financing round. Spearheaded by Columbus Venture Partners, this funding will accelerate the company’s innovative work on thymus preservation, regeneration, and manipulation therapies aimed at treating a range of immune-mediated diseases. Founded by industry…

Read More

Blacksmith Medicines Secures FDA QIDP and Fast Track Status for FG-2101, Advancing Critical Fight Against Drug-Resistant Gram-Negative Infections

In a significant milestone for antibiotic innovation, Blacksmith Medicines has been granted both Qualified Infectious Disease Product (QIDP) and Fast Track designations by the U.S. Food and Drug Administration (FDA) for its novel antibiotic candidate, FG-2101. This small molecule inhibitor targets LpxC, a metalloenzyme essential to the survival of Gram-negative bacteria, including multidrug-resistant strains—an area…

Read More